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Regioselective addition of allylmercaptan at the C-3 position adjacent to the nitrogen 
carrying phenyl group of the 1,4-phenylenediamine moiety of 1−4 was rigorously 
confirmed by the 1D NOE difference in combination with gHMBC experiments. The 
structures of 1,4-phenylenediamines 1−4, allylsulfanyl-N1-alkyl-N4-phenyl-1,4-
phenylenediamines 5−8, and cyclization products 9−14 were completely analyzed in both 
CDCl3 and DMSO-d6 solutions. The 1H and 13C NMR spectra of 10 and 11 containing 
two chiral centers exhibit duplication for several signals indicating the existence of two 
diastereomeric forms. The full structures of 5 and 9 were unambiguously confirmed by 
X-ray crystallography. The 1H and 13C NMR spectra of all compounds were assigned 
using one and two-dimensional NMR techniques (APT, DEPT, 1D NOE difference, 
COSY, NOESY, HETCOR, gHMQC and gHMBC). 
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INTRODUCTION 
 
N1-(Alkyl)-N4-phenyl-1,4-phenylenediamines, such as N1-isopropyl-N4-phenyl-1,4-
phenylenediamine (IPPD), N1-(4-methyl-2-pentyl)-N4-phenyl-1,4-phenylenediamine 
(DMBPPD), and N1-(2-octyl)-N4-phenyl-1,4-phenylenediamine  (OPPD), have been used 
as antioxidants in rubber products.1a-c  These compounds commonly display sensitizing 
properties,2a-b and have been associated with contact dermatitis.3a-d  OPPD was reportedly 
added to tire sidewalls primarily to make them resistant to ozone.4a-b  
The importance and utility of 1,4-phenylenediamines2b led us to study approaches to 
thio-substituted derivatives5a and cyclized analogs.5b   Most of this work involved addition 
of mercapto compounds to an N1- alkyl-N4-aryl-p-quinonediimine B, which could lead to 
regioisomers A, or C (Scheme 1). Michael additions of thiols are well studied.6a-c  
Insert Scheme 1 here 
Experimentally, we found that in almost all cases, a single isomer predominated for 
the product and this was considered to be regioisomer A.5a-b Later work disclosed a 
considerably more complex picture: whereas heterocyclic thiones (tautomeric with 
heterocyclic thiols) indeed give regioisomers A,7  most  alkylthiols form regioisomers 
C7,8 as demonstrated by 1D (NOE difference, coupled 13C NMR spectra, APT and DEPT) 
and 2D NMR techniques (DQCOSY, NOESY, HETCOR, and heteronuclear multiple 
bond coherence HMBC).7-8 Specifically, the incorrect structures given in references 5a 
and 5b have  been corrected in references 7 and 8. 
Thiol adducts of quinonediimines derived from certain functionalized thiols, e.g. 
methyl 3-mercaptopropionate and mercaptopropionic acid, could cyclize in the pattern of 
C3-C4-N4 II and C1-C2-N1 III (Scheme 2). Several representative examples have 
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already been examined and their structures8 fairly established by 2D NMR techniques 
such as gHMQC, gHMBC.   
Insert Scheme 2 here 
In the present paper, we extend this work and report the synthesis of allylsulfanyl-
N1-phenyl-1,4-phenylenediamines 5−8 and their thermal cyclization products 9−12 
involving C2 and C3 atoms of the  1,4-phenylenediamine moiety (Scheme 2, IV). 
Structure elucidation of 1−14 was achieved using gradient selected experiments. In 
several cases, COSY, NOESY and HETCOR (without gradients) experiments were used. 
RESULTS AND DISCUSSION 
Reaction of N1-alkyl-N4-phenyl-1,4-phenylenediamines 1−4 with silver oxide and 
magnesium sulfate in toluene at room temperature led to the formation of the 
corresponding phenylenediimines,  which in situ reacted with allyl mercaptan in ethanol 
at 25 oC to afford allylsulfanyl-N4-phenyl-1,4-phenylenediamines 5−8 in 60−70% yields. 
Regioselective addition of the S-allyl group at the C-3 position (not at C-2 position) of 
the 1,4-phenylenediamine moiety was rigorously confirmed by 1D NOE difference 
spectra in combination with gHMBC experiments. Thermal cyclizations of 5−8 under 
nitrogen at 150 oC resulted in the formation of 2,3-dihydro-1-benzothiophenes 9−12, in 
the two cases in admixture with 3,4-dihydro-2H-thiochromans 13 and 14 (Scheme 3).  
Insert Scheme 3 here 
The formation of the cyclized products 9−14 involvs a thio-Claisen rearrangement as 
the first step followed by Markovnikov and anti-Markovnikov addition of SH to the 
double bond.  
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1H NMR spectra of N1-alkyl-N4-phenyl-1,4 –phenylenediamines 1−4 
Complete analysis of the 1H NMR spectra of 1−4 was achieved in CDCl3 and DMSO-d6 
solutions using 1D NOE difference and COSY experiments. The 1H NMR assignments 
are given in Table 1 (numbering of atoms does not correspond to IUPAC nomenclature).  
Insert Table 1 here 
In the 1H NMR spectra of 1−4 in CDCl3 solution the H-2/H-6 and H-3/H-5 
resonances exhibit AB type doublets (3J2,3 = 3J5,6 = 9 Hz) at ca δ 6.54 and at ca δ = 6.89 
respectively. This was further confirmed by the assignments of proton chemical shifts 
based on a series of NOE difference experiments: thus, the following nOe’s were 
observed when 1-NH (at δ = 3.23−3.32) and 4-NH (at δ = 5.29–5.36) resonances were 
irradiated: from 1-NH to H-2/H-6 at ca δ = 6.54 and from 4-NH to H-3/H-5 at δ = 6.89 
and to multiplets of ortho N4-phenyl protons centered at δ = 6.81.  
Compound 4 shows the expected conformational behavior for the cyclohexyl moiety, 
which exists in a chair conformation, with the bulkier group (1,4-phenylenediamine), 
occupying the equatorial position, i.e. the H-8 in 4 is axial (Scheme 4). Similar behavior 
for the cyclohexyl moiety was documented for cyclohexyl amines.9   
Insert Scheme 4 here 
13C NMR spectra of 1−4 
Carbon-13 chemical shift assignments of 1−4 in both CDCl3 and DMSO-d6 solutions 
experiments are summarized in Table 2. 
Insert Table 2 here 
In the 13C NMR spectra of 1−4 the C-3/C-5 resonances appears in relatively downfield 
positions, at δ = 124.0, compared to C-2/C-6 (at δ = 114.0). Distinction between two 
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quaternary carbons (C-1 and C-4) in 1−4 was supported by strong three bond HMBC 
correlations from H-2/H-6 to C-4 at ca δ = 132.0 and from H-3/H-5 to C-1 at δ = 144.0 
1H NMR spectra of 3- allylsulfanyl-N1-alkyl-N4-phenyl-1,4 –phenylenediamines 5−8 
The assigned proton chemical shifts of 5−8 (in both CDCl3 and DMSO-d6) are given in 
Table 3. 
Insert Table 3 here 
A characteristic coupling constant of the 1,4-phenylenediamine moieties in the range 
ca 2.5–2.8 Hz (4J2,6) attributable to meta coupled proton pairs as in  substituted benzenes  
is assigned to H-2 resonances in the range  δ 6.53–6.54 (DMSO-d6). The doublets in the 
range δ 6.87−6.93 with a 3J of 8.5 Hz belong to H-5 resonances. The measured values of 
8.5 Hz  (3J) and 2.6 Hz (4J) is close to published 1H NMR data for trisubstituted benzenes 
in the range 8.4−9.0 Hz (3J) and 1.7–3.0 Hz  (4J).10a-b 
The structure of 5 was unambiguously confirmed by X-ray crystallography (Fig. 1).  
Insert Figure 1 here  
The assignments of S-allyl protons designated a, b, c, d (Table 3, for designation of 
allyl protons see Scheme 5) were based on COSY correlations and also on the magnitude 
of 3J (cis or trans) coupling constants.  
Analysis of coupling constants  (2Jab, 3Jcd, 3Jtrans, 3Jcis) was performed using simulation 
spectra. It seems that multiplicity of geminal coupled Ha and Hb resonances can not be 
analyzed as first order spectra in CDCl3 solutions because of superpositions of several 
transitions for lines of Ha and Hb (Δν/J ≈ 1). Sequences of double irradiation experiments 
were used for the determination of coupling constants. Experimentally determined 
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chemical shifts and coupling constants of Ha and Hb were examined using simulation 
spectra.  
 In the 1H NMR spectra of 5−8 recorded in CDCl3 solution, the signal at δ 4.99 
(doublet of doublet of doublets, 3Jac = 16.9, 2Jab ≈ 1.0 and 4Jad ≈ 1.4) was assigned to Ha 
and    the relatively high frequency doublet of doublets of triplets (ddt, 3Jca = 16.9, 3Jcb = 
10.0, 3Jcd = 6.8 Hz) was assigned to Hc. The portion of 1H NMR spectrum (Fig. 2) of 8  
for the allylic protons is given as representative example. 
Insert Figure 2 here 
 In contrast to the 1H NMR spectra of 5−8 recorded in CDCl3 solution the 1H NMR 
spectra of 5−8 in DMSO-d6 solutions for the allyl protons gave ABMX2 type spectra, 
where the AB part is related to the Ha and Hb and MX2 to protons Hc and SCH2.  
Coupling through two bonds by 1.0 Hz is close to the published values of 2J for 2-
substituted propenes11 and 1-substituted 2-methylpropenes.12a-d The allylic coupling 
constant (4Jad and 4Jbd) does change considerably with the introduction of different 
substituents at 1-NH.  The measured values of coupling constants are listed in Table 5.  
The observed coupling constant for protons on adjacent trigonal (Hc) and tetrahedral 
carbons, 3J(Hc, SCH2) depends on conformation giving a value near 7.0 Hz when these 
protons are trans oriented. The long-range allylic coupling constants also depend on the 
rotational conformation having the smallest value when allylic proton and the =CH2 
group are eclipsed. Introduction of a bulkier 1,4-phenylene group increases the 
populations of forms i) and ii) at the expense of iii). The value of 7.1 Hz between Hc and 
SCH2 protons is in good agreement with published data for the same coupling constants 
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in several olefins.11,12a-d Stable conformations for S-allyl substituents are illustrated in 
Scheme 5. 
Insert Scheme 5 here 
13C NMR spectra of 5−8 
 The assigned carbon-13 chemical shifts of 5−8 are summarized in Table 4. 
Insert Table 4 here 
Long-range HMBC correlations through three bonds (3J) between 4-NH and C-3 
(quaternary carbon) in the range ca δ = 134.0 and C-5 at δ = 127.0 (protonated carbon) 
unambiguously confirmed addition of the allylsulfanyl group at the C-3 position of 1,4-
phenylenediamine moiety. Distinction of chemical shifts of quaternary carbons C-1 and 
Cipso/Ph was made on the basis of HMBC cross peaks. The contour plot of gHMBC 
spectra of 5−8 (in DMSO-d6 solution) displayed three bond cross peaks between Cmeta/Ph 
and Cipso/Ph in the range δ = 145.28−147.81 and between CHN1 and C-1 of the 1,4-
phenylediamine moiety in the range δ = 146.06–145.75. The contour plot of the gHMBC 
spectra revealed for H-2 and H-6 protons show strong three bond correlations to the 
carbon signal at ca δ = 128.0, which was assigned definitively to C-4. The gHMBC cross 
peaks through three bonds between H-5 and a carbon signal at δ = 134.0 and also 
between the SCH2 and a carbon signal at δ = 134.0 confirmed unambiguously the 
assignment of C-3. 
The assigned chemical shifts values of the N1-alkyl groups for 5−8, in particular 
assignments of C-3 and C-5 resonances, were based on three bond correlations between 
6-CH3 and C-5 (δ = 31.34) and between H-1 and C-3 (δ = 28.84) in 7 for the 2-octyl 
group is similar to published 13C NMR data for acyclic aliphatic amines.13  
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1H NMR spectra of N4-(alkyl)-2-methyl-N7 phenyl-2,3-dihydro-1-benzothiophene-4,7-
diamines 9−12 
The assigned 1H NMR data for compounds 9−12 are listed in Table 5. 
Insert Table 5 here 
 For assignment of the protons in 9, a series of 1D NOE difference experiments was 
performed (Fig. 3). The assignments of H-3β/H-2β, 2-CH3 and H-3α were initially based 
on the magnitude of the vicinal coupling constant observed in the five-membered ring.14 
In these sulfur and nitrogen containing compounds, the trans vicinal coupling was smaller 
than the cis vicinal coupling. In the 1H NMR spectrum of 9 recorded in DMSO-d6 
solution the H-3α resonance appears in a relatively low frequency region at δ = 2.79 
compared to H-3β (δ = 3.25). The established assignments were supported by a sequence 
of NOE experiments. Irradiation of the 2-CH3 resonance at δ = 1.44 resulted in nOe 
enhancements for protons at δ = 2.79 (H-3α) and H-2 at δ = 3.89 (Fig. 2c). The nOe’s 
also were observed between H-2β at δ = 3.89 and H-3β at δ = 3.25 and 2-CH3  (δ = 1.33) 
when H-2β was irradiated. The nOe effects from H-9 (δ = 3.54) and 7-NH (δ 7.04) to 
protons H-5 at δ = 6.30 and H-6 at δ 6.80 respectively are conclusive (Fig. 3d and 3g). 
Insert Figure 3 here  
The full structure of 9 was unambiguously determined by single crystal X-ray 
crystallography. It crystallizes in the triclinic space group P-1, again with two molecules 
in the asymmetric unit, each of which has the five membered ring disordered with the 
methyl group in two positions (Fig. 4).  
Insert Figure 4 here 
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In the 1H NMR spectrum of 9 in CDCl3 solution, the H-3 protons appear as doublets 
of doublets of doublets (ddd) at δ 2.75 and δ 3.22  (2J3α,3β = 14.9, 3J3α,2β = 7.9 and 6J3β,6 ≈ 
6J3α,6 ≈ 0.7 Hz). To confirm the long-range coupling constant through six bonds   (6J) a 
long-range COSY experiment was run with 200 ms mixing time. The contour plot of the 
COSY spectrum of 9 revealed off diagonal cross peaks for both H-3 protons at δ = 2.75 
and δ = 3.22 respectively, proving couplings to H-6 (δ = 2.75). 
The 1H NMR spectral characterization of the diastereomeric forms of 10 and 11  
Compounds 10 and 11 containing two chiral centers exhibit in their 1H and 13C NMR 
spectra doubling of several signals, indicating the presence of two diastereomeric forms. 
In fact, the relative configuration of methyl substituents at C-2 in the benzothiophene 
moiety and at C-9 of the alkyl moieties was impossible to be determined. 
However, each diastereomer can be partially characterized by 1H and 13C NMR data. 
Both diastereomeric forms I and II show nonequivalence for the 2-methyl, methylene (3-
CH2 and 10-CH2), 11-CH3A and 11-CH3B and 4-NH in their 1H NMR spectra (Table 5). 
The 1H NMR spectrum of 10 for the methyl region in CDCl3 is shown in Fig. 5.  
Insert Figure 5 here 
Similarly to 9, the H-3 protons in 10 and 11 show long-range coupling of ca 0.7 Hz 
via six bonds to H-6 at δ = 6.82 and δ = 6.80 respectively. A series of double resonance 
and long-range COSY experiments for 10 were performed to confirm spin-spin 
interaction between H-3α (or H-3β) and H-5 and H-6 of the benzothiophene moiety (Fig. 
6). 
Insert Figure 6 here 
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The pair of chemical shifts for H-3 at δ = 2.75/δ 2.82 and at δ = 3.23/δ 3.29 in 10 and 
at δ = 2.76/2.82 and at δ = 3.23/3.27 in 11   (see Table 5) clearly show the presence of 
two diastereomers (I and II) for both compounds. 
The values of geminal coupling constants of 15.8 Hz between geminal coupled H-3 
protons, and vicinal coupling of 6.6 Hz between cis oriented H-3β and H-2β and transoid 
vicinal coupling of 7.9 Hz between H-3α and H-2β for both compounds 10 and 11 are the 
same. 
13C NMR spectra of 9−12 
The assigned carbon-13 chemical shifts (in both CDCl3 and DMSO-d6) of 9−12 are listed 
in Table 6. 
Insert Tables 6 here 
In contour plots of HMBC spectra of 9−12 the H-2 signals show two bond 
correlations to C-3 at δ ≈ 42.0 and three bond correlations to two quaternary carbons C-
3a and C-7a at δ ≈ 124.0 and at δ ≈ 138.0, respectively. Assignments of C-3a and C-7a 
were corroborated additionally, on the basis of the HMBC cross peaks between C-3a and 
H-5 at δ ≈ 6.36 and between C-7a and H-6 at δ ≈ 6.98. The contour plot of HMBC 
spectra of 9−12 reveals strong cross peaks between H-5 at δ ≈ 6.36 and quaternary carbon 
C-7 at δ ≈ 126.0, strong cross peaks were observed between H-6 at δ ≈ 6.98 and 
quaternary carbon C-4 at δ ≈ 141.0. The C-5 (at δ ≈ 108.0) and C-6  (δ ≈ 123.86–123.90) 
resonances were assigned on the basis of one bond-heterocorrelation peaks observed in 
contour plots of gHMQC spectra in CDCl3 solution. Assignments of N1-alkyl and N4–
phenyl carbons are based on one-bond HMQC correlations. 
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1H NMR spectra of N5-(isopropyl)-N8-phenyl-5,8-thiochromanediamine 13 and N5-
(cyclohexyl)-N8-phenyl-5,8-thiochromanediamine 14 
The assigned proton chemical shifts of 13 and 14 are given in Table 7. 
Insert Table 7 here 
1H NMR chemical shift values are similar to those of 9−12. The relatively high field 
region at δ = 6.35 and at δ = 6.36 were assigned to H-6. For 13 and 14, the H-7 
resonances appear at δ = 6.81 and at δ = 6.80, respectively. In the 1H NMR spectra of 13 
and 14 the sulfur containing six membered ring protons exhibit multiplets centered at δ = 
2.00 and at δ = 2.80, which were assigned to H-3 and H-4. For both compounds, H-2 
appears as a triplet δ = 2.48 and δ = 2.47 with a coupling constant of 6.3 Hz. Connectivity 
of H-2, H-3 and H-4 was based on three bond COSY correlations and was supported by 
selective irradiation experiments. 
13C NMR spectra of 13 and 14 
The assigned carbon-13 chemical shifts of 13 and 14 in both CDCl3 and DMSO-d6 
solutions data are given in Table 8. 
Insert Table 8 here 
The SCH2 protons of 13 and 14 at δ = 2.48 and δ = 2.47 respectively are correlated 
with the directly bound carbon resonances at δ = 23.37 and δ = 23.35. These protons also 
show long-range coupling to a methylene carbon at δ = 25.40 (C-4 of 13), δ  = 25.61 (C-4 
of 14) and quaternary carbons at δ = 132.12 (in 13) and δ = 132.18 (in 14). The H-3 (δ  = 
1.98–2.04 and δ = 1.99−2.04) show long-range coupling through three bonds to a 
quaternary carbon, C-4a, at δ = 118.45 and δ = 118.30. Assignments of quaternary 
carbons C-4a and C-8a in 13 were additionally confirmed by examining the three bond 
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couplings from H-6 (δ = 6.35) and H-7 (δ = 6.81) protons. Both quaternary carbons (C-4a 
and C-8a) in 14 exhibit cross peaks in the contour plot of the HMBC spectrum due to 
long-range coupling to the H-6 and H-7 protons at δ = 6.36 and δ  = 6.80 respectively. 
In solving the resonance assignments of quaternary carbons C-5 and C-8 the long-
range correlations between H-6 (δ = 6.35) and C-8 at δ = 126.72 and between the H-9 at 
δ = 3.57 and quaternary carbon, C-5 at δ = 143.39 are conclusive. The SCH2 show long-
range correlations in 14 between H-6 (δ = 6.36) and quaternary carbon, C-8 at δ = 126.76 
and between a multiplet centered at δ = 3.28 and a quaternary carbon, C-5, at δ = 143.16. 
CONCLUSION 
1D NOE difference experiments in combination with gHMBC experiments confirmed the 
regioselective addition of allyl mercaptan to the 3-position of the 1,4-phenylenediamine 
moiety of 1−4. The structure of 5 as a representative example of 5−8 was confirmed by 
X-ray crystallography. Further we established using 2D NMR techniques the structures of 
cyclized products 9−14. The structure of 9 additionally was confirmed by X-ray analysis. 
The assignments of 1−14 provide vital information on the chemistry of N1-alkyl-N4-
phenyl-1,4-phenylenediamines. 
EXPERIMENTAL 
The 1D and 2D NMR experiments were performed using a Mercury 300 MHz (Varian) 
NMR machine equipped with a 5 mm PFG switchable probe. Chemical shifts are 
reported in ppm from tetramethylsilane (TMS) used as internal standard (δH = 0).  
The 1H NMR spectra were acquired at 298 K with 32 scans (nt), 4 KHz spectral width 
(sw), 32 K data points (np) in the time domain, a 4 s acquisition time (at), a 2 s relaxation 
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delay (d1) and 4.5 μs pulse 30o pulse width (pw). The FID’s were zero filled to 128 K 
and multiplied by Lorentz-Gauss window functions (lb = -0.5 and gb = 0.4).  
The 13C NMR spectra were acquired using a 5.1 μs (pulse width 30o), a 1.8 s 
acquisition time, a spectral width of ca 12000 Hz and WALTZ decoupling. The FID’s 
were zero-filled to 128 K. 
For the NOE difference experiments, the NMR sample was prepared by dissolving ca 
15 mg of a compound in 0.7 mL CDCl3 in 5 mm NMR tube. The tube was purged with 
argon to remove dissolved oxygen for 1 min before running NOE experiments. 
The COSY spectra were acquired with a spectral width of 3 KHz in  F1 and F2 
dimensions. A sinebell and shifted sine bell window functions was used in both 
dimensions. The FID’s in both dimensions were zero-filled to 2048. 
The NOESY spectra were recorded also with a spectral width of 3 KHz in both 
dimensions using 1024 x 1024 data matrix and 512 time increments of each 16 scans 
(mix time 0.8 s), in phase-sensitive mode, and processed with gauss apodization function.  
For the HETCOR spectra, the conditions were as follows: spectral width of ca 12 
KHz for 13C and ca 3 KHz for 1H spectra, pulse width 90o (13.5 μs for 1H, 15.3 μs for 
13C), relaxation delay 1.0 s, number of increments 256 or 512, FT size 2048x1024. The 
FID’s were processed using sinebell functions (sb and sbs). 
The gHMQC and gHMBC spectra were acquired at 25 oC on 20 mg samples in 0.7 
mL CDCl3 and DMSO-d6 solutions with a 0.4 s acquisition time, 2048 data points, a 2500 
Hz spectral width in F2, 10500 Hz spectral width in F1, a 15.6 μs 13C 90o pulse width, 32 
dummy cycles, 16 scans and with 512 increments. The FID’s were processed using 
Gaussian functions (gf and gfs) and were zero filled to 1024 x 2048 data size. 
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Synthesis  
General procedure for the preparation of N1-alkyl-2-(allylsulfanyl)-N4-phenyl-1,4-
benzenediamines 5−8  
To a solution of N1-alkyl-N4-phenyl-p-phenylenediamines 1−4 (5 mmol) in toluene (30 
mL) was added Ag2O (10 mmol) and MgSO4 (14 mmol) consecutively at room 
temperature. The resulting suspension was stirred at room temperature overnight (around 
15h). After filtration (Celite) and evaporation of toluene, the residue was dissolved in 
ethanol (50 mL), and then allyl mercaptan (0.5 mL, 5 mmol) was added dropwise at room 
temperature. The final mixture was stirred at r.t for 2-22 h. Upon removal of ethanol, the 
residue was purified by column chromatography on silica gel (hexane/ethyl acetate, 50/1) 
to give N1-alkyl-2-(allylsulfanyl)-N4-phenyl-1,4-benzenediamines 5−8. 
 3-(Allylsulfanyl)-N1-isopropyl-N4-phenyl-1,4-benzenediamine (5). Yellow prism, mp 
60.0−61.0 oC (67%). Anal. Calcd for C18H22N2S: C, 72.44; H, 7.43; N, 9.39.  Found: C, 
72.26; H, 7.70; N, 9.29.  
3-(Allylsulfanyl)-N1-(4-methyl-2-pentyl)-N4-phenyl-1,4-benzenediamine (6). Yellow 
oil (65%). Anal. Calcd for C21H28N2S: C, 74.07; H, 8.29; N, 8.23.  Found: C, 73.98; H, 
8.63; N, 8.48.  
3-(Allylsulfanyl)-N1-(2-octyl)-N4-phenyl-1,4-benzenediamine (7). Yellow oil (68%). 
Anal. Calcd for C23H32N2S: C, 74.95; H, 8.75; N, 7.60.  Found: C, 74.80; H, 8.96; N, 
7.70.  
3-(Allylsulfanyl)-N1-cyclohexyl-N4-phenyl-1,4-benzenediamine (8). Yellow oil (63%). 
Anal. Calcd for C21H26N2S: C, 74.51; H, 7.74; N, 8.28.  Found: C, 74.85; H, 8.07; N, 
8.63.  
 15
General procedure for N4-(alkyl)-2-methyl-N7-phenyl-2,3-dihydro-1-
benzothiophene-4,7-diamines 9-12 and N5-(isopropyl)-N8-phenyl-5,8-
thiochromanediamine 13 and N5-(cyclohexyl)-N8-phenyl-5,8-thiochromanediamine 
14 
Under nitrogen, the N1-alkyl-2-(allylsulfanyl)-N4-phenyl-1,4-benzenediamines 5−8 (2 
mmol) was heated at 150−155 oC overnight. After cooling to room temperature, the 
reaction mixture was subject to column chromatography on silica gel by gradual elution 
(hexane; hexane-ethyl acetate, 50:1) to give pure products. In cases 9 and 12, N5-
(isopropyl)-N8-phenyl-5,8-thiochromanediamine 13 and N5-(cyclohexyl)-N8-phenyl-5,8-
thiochromanediamine 14 were isolated as the first fraction and corresponding minor 
product, respectively. 
N4-Isopropyl-2-methyl-N7-phenyl-2,3-dihydro-1-benzothiophene-4,7-diamine (9). 
Yellow prism, mp 76.0−78.0 oC (54%). Anal. Calcd for C18H22N2S: C, 72.44; H, 7.43; N, 
9.39.  Found: C, 72.22; H, 7.73; N, 9.27.  
2-Methyl-N4-(4-methyl-2-pentyl)-N7-phenyl-2,3-dihydro-1-benzothiophene-4,7-
diamine (10). Yellow oil (75%). Anal. Calcd for C21H28N2S: C, 74.07; H, 8.29; N, 8.23.  
Found: C, 74.11; H, 8.50; N, 8.22.  
2-Methyl-N4-(2-octyl)-N7-phenyl-2,3-dihydro-1-benzothiophene-4,7-diamine (11). 
Yellow oil (65%). Anal. Calcd for C23H32N2S: C, 74.95; H, 8.75; N, 7.60.  Found: C, 
75.30; H, 9.16; N, 7.62.  
N4-Cyclohexyl-2-methyl-N7-phenyl-2,3-dihydro-1-benzothiophene-4,7-diamine (12). 
Yellow oil (53%). Anal. Calcd for C21H26N2S: C, 74.51; H, 7.74; N, 8.28.  Found: C, 
74.83; H, 8.19; N, 8.14. 
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N5-isopropyl-N8-phenyl-5,8-thiochromanediamine (13). White needles, mp 99.0−101.0 
oC (11%). Anal. Calcd for C18H22N2S: C, 72.44; H, 7.43; N, 9.39.  Found: C, 72.69; H, 
7.68; N, 9.36.  
N5-Cyclohexyl-N8-phenyl-5,8-thiochromanediamine (14). Yellow oil (11%). Anal. 
Calcd for C21H26N2S: C, 74.51; H, 7.74; N, 8.28.  Found: C, 74.60; H, 8.18; N, 8.08. 
X-ray crystallography  
Data were collected with a Siemens SMART CCD area detector, using graphite 
monochromatized MoKα radiation (λ = 0.71073 Å). The structures were solved by direct 
methods using SHELXS15  and refined on F2, using all data, by full-matrix least-squares 
procedures using SHELXTL.16 Hydrogen atoms were included in calculated positions, 
with isotropic displacement parameters 1.2 times the isotropic equivalent of their carrier 
carbons, except for the NH hydrogens which were found in difference maps and their 
positions refined. 
Crystal data for 5: C16H22N2S, MW 298.44, monoclinic, P21/c, a = 25.284(3), b = 
12.290(1), c = 10.931(1) Å, β = 100.430(2) o, V = 3340.6(6) Å 3, Z = 8, T = -105 oC, 
F(000) = 1280, μ (MoKα) = 0.190 mm-1, Dcalcd = 1.187 g.cm-3, 2θmax 45o (CCD area 
detector, 99.8% completeness), wR(F2) =  0.0663 (all 4357 data), R = 0.0346 (2356 data 
with I > 2σI). 
Crystal data for 9: C16H22N2S, MW 298.44, triclinic, P-1, a = 9.018(1), b = 
10.739(2), c = 17.775(2) Å, α = 80.971(2), β = 81.651(2), γ = 73.782(2) o, V = 1623.1(4) 
Å 3, Z = 4, T = -105 oC, F(000) = 640, μ (MoKα) = 0.195 mm-1, Dcalcd = 1.221 g.cm-3, 
2θmax 45o (CCD area detector, 99.3% completeness), wR(F2) =  0.1137 (all 4223 data), R 
= 0.0517 (2728 data with I > 2σI). 
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  Table 1.  Proton chemical shift assignments of  N1-alkyl-N4-phenyl-1,4-benzenediamines  1-4 
 
Comp Solvent H-2/H-6 H-3/H-5 4-NH 1-NH H-8 8-CH3A 8-CH3B 
1 CDCl3 6.53 – 6.58 
      (m) 
6.95 – 7.19 
      (m) 
5.32 
(br s) 
3.28 
(br s) 
3.57 
(sept, 6.3) 
1.18 
(d, 6.3) 
1.18 
(d, 6.3) 
 DMSO-d6 6.52 – 6.57 
      (m) 
6.79 – 6.99 
      (m) 
7.46 
(br s) 
4.96 
(br s) 
3.48 
(sept, 6.4) 
1.12 
(d, 6.3) 
1.12 
(d, 6.3) 
2a CDCl3 6.53 – 6.58 
      (m) 
6.96 – 7.01 
     (m) 
5.36 
(br s) 
3.25 
(br s) 
3.48 
(sext, 6.4) 
1.15 
(d, 6.2) 
1.26 (dt, 13.6, 6.9)* 
1.47 (dt, 13.6, 7.0) 
 DMSO-d6 6.49 – 6.55 
     (m) 
6.84 – 6.89 
     (m) 
7.46 
(br  s) 
4.95 
(br d, 8.8) 
3.38 
(sept, 6.6) 
1.06 
(d, 6.3) 
1.19(dt, 13.4. 6.9) * 
1.44 (dt, 13.4, 7.0) 
3b CDCl3 6.51 – 6.57 
     (m) 
6.95 – 7.00 
    (m) 
5.34 
(br s) 
3.23 
(br s) 
3.39 
(sext, 6.1) 
1.16 
(d, 6.3) 
1.52 – 1.59 (m)* 
1.37 – 1.44 (m)* 
 DMSO-d6 6.49 – 6.55 
     (m) 
6.84 – 6.90 
    (m)  
7.45 
(br  s) 
4.96 
(br d, 8.4) 
3.31 
(sept, 6.6) 
1.08 
(d, 6.2) 
1.46 – 1.56 (m)* 
1.31 – 1.39 (m)* 
4 CDCl3 6.52 – 6.58 
     (m) 
6.93 – 6.99 
    (m) 
5.29 
(br s) 
3.32 
(br s) 
3.19 
(tt, 10.2, 3.7) 
   ─          ─ 
 DMSO-d6 6.51 – 6.55 
     (m) 
6.84 – 6.89 
     (m) 
7.45 
(br s) 
5.05 
(br s) 
3.11 
(unresolv m) 
    ─          ─ 
  N4-Phenyl ring protons   
Comp Solvent                ortho/Ph                      meta/Ph                 para/Ph 
1 CDCl3 6.79 – 6.83 (m) 6.72 – 6.78 (m) 6.72 – 6.78 (m) 
 DMSO-d6 6.79 – 6.83 (m) 7.05 – 7.11 (m) 6.57 – 6.63 (m) 
2 CDCl3 6.79 – 6.84 (m) 7.13 – 7.20 (m) 6.72 – 6.83 (m) 
 DMSO-d6 6.74 – 6.79 (m) 7.04 – 7.11 (m) 6.56 – 6.62 (m) 
3 CDCl3 6.78 – 6.82 (m) 7.12 – 7.19 (m) 6.72 – 6.78 (m) 
 DMSO-d6 6.55 – 6.62 (m) 7.04 – 7.11 (m) 6.75 – 6.81 (m) 
4 CDCl3 6.78 – 6.82 (m) 7.11 – 7.19 (m) 6.71 – 6.77 (m) 
 DMSO-d6 6.56 – 6.62 (m) 6.75 – 6.80 (m) 7.04 – 7.11 (m) 
 
a) 2 in CDCl3: * - 9 – CHAHB, 1.76 (sept, 6.8, H-10), 0.91 (d, 6.6, 10-CH3A), 0.94 (d, 6.5, 10-CH3B);  b) 3 in CDCl3:  1.25 – 1.43 (m,  
10-CH2 + 11-CH2 + 12-CH2 + 13-CH2), in DMSO-d6:  1.18 – 1.39 (m,  10-CH2 + 11-CH2 + 12-CH2 + 13-CH2) 
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Table 2.  Carbon-13 chemical shift assignments of  N1-alkyl-N4-phenyl-1,4-benzenediamines  1-4 
 
 
Comp Solvent C-1 C-2/ 
C-6 
C-3/C-5 C-4 C-8 8-CH3A 
 
C-9 C-10 10-
CH3A 
C-11 C-12 
1a CDCl3 143.78 114.16 123.91 132.18 44.65 23.00 – – – – – 
 DMSO-d6 143.72 113.32 122.59 131.28 43.49 22.58 – – – – – 
2b CDCl3 144.09 113.93 124.11 131.97 46.96 21.01 46.91 25.07 22.40 – – 
 DMSO-d6 143.91 112.99 122.65 131.00 46.05 20.73 45.76 24.52 22.57 – – 
3c CDCl3 144.07 113.97 124.05 131.97 48.96 20.76 37.21 29.34 – 26.10 31.80 
 DMSO-d6 143.95 113.04 122.64 131.01 47.75 20.42 36.42 28.90 – 25.73 31.37 
4 CDCl3 143.68 114.05 123.98 132.02 52.16 – 33.48 24.98 – 25.87 – 
 DMSO-d6 143.58 113.10 122.66 131.03 50.99 – 32.76 24.63 – 25.26 – 
   N4-phenyl ring carbons     
Comp Solvent C
ipso Cortho Cmeta Cpara 
1 CDCl3  146.25   114.68   129.13  118.56 
 DMSO-d6  146.68   113.66   128.90  116.99 
2 CDCl3  146.37   114.65   129.17  118.55 
 DMSO-d6  146.67   113.56   128.82  116.85 
3 CDCl3  146.35   114.63   129.14  118.52 
 DMSO-d6  146.72   113.55   128.85  116.85 
4 CDCl3  146.30   114.61   129.11  118.49 
 DMSO-d6  146.72   113.52   128.88  116.87 
a)  1 in CDCl3: δ 23.0 (8-CH3B), in DMSO-d6: δ 22.58 (8-CH3B); b) 2 in CDCl3: δ 22.96 (10-CH3B), in DMSO-d6: δ 22.71 (10-CH3B);  c) 3 in CDCl3:  
δ 22.59 (C-13),  δ 14.06 (C-14) , in DMSO-d6: δ 22.10 (C-13),  δ 13.93 (C-14) 
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       Table   3.  Proton chemical shift assignments of   3-allylsulfanyl-N1-alkyl-N4-phenyl-1,4-benzenediamines  5-8  
 
Comp Solvent H-2 H-5 H-6 Ha Hb Hc SCH2 1-NH 4-NH 
 
5 
CDCl3 6.72 
(d, 2.8) 
7.14 
(d, 8.6) 
6.49 
(dd, 8.6, 2.8) 
5.00 
(dq, 16.9, 1.4) 
 
4.98 
(dq, 10.0, 0.8) 
 
5.81 
(ddt, 16.9, 10.0, 7.1) 
3.36 
(dt, 7.1, 1.1) 
3.21 
(br s) 
6.00 
(br s) 
 
 
 
DMSO-d6 6.54 
(d, 2.5) 
 
6.89 
(d, 8.5) 
 
6.39 
(dd, 8.5, 2.5) 
5.19 
(dq, 16.9, 1.5) 
5.05 
(dq, 10.1, 1.0) 
 
5.82 
(ddt, 16.9, 10.1, 6.8) 
3.48 
(dt, 6.8, 1.2) 
5.31 
(br s) 
6.96 
(br s) 
6a 
 
 
CDCl3 6.70 
(d, 2.7) 
 
7.13 
(d, 8.6) 
 
6.48 
(dd, 8.6, 2.7) 
 
5.05 
(dq, 17.2, 1.4) 
 
4.99 
(dq, 10.1, 0.9) 
5.81 
(ddt, 17.2, 10.1, 7.1) 
 
3.36 
(dt, 7.1, 1.1) 
3.10 
(br s) 
5.88 
(br s) 
 DMSO-d6 6.53 
(d, 2.6) 
6.93 
(d, 8.5) 
 
6.38 
(dd, 8.5, 2.6) 
 
5.19 
(dq, 17.0, 1.4) 
 
5.06 
(dq, 10.1, 0.9) 
5.82 
(ddt, 17.0, 10.1, 6.8) 
3.47 
(dt, 6.8, 1.0) 
 
5.25 
(br d, 8.5) 
6.95 
(br s) 
7b 
 
 
CDCl3 6.70 
(d, 2.8) 
 
7.14 
(d, 8.6) 
 
6.49 
(dd, 8.6, 2.8) 
 
5.01 
(dq, 16.9, 1.4) 
 
4.99 
(dq, 10.0, 0.9) 
 
5.82 
(ddt, 16.9, 10.0, 7.2) 
 
3.37 
(dt, 7.2, 1.1) 
3.26 
(br s) 
5.98 
(br s) 
 DMSO-d6 6.53 
(d, 2.5) 
6.88 
(d, 8.5) 
6.38 
(dd, 8.5, 2.5) 
5.19 
(dq, 16.9, 1.4) 
 
5.05 
(dq, 10.0, 0.9) 
 
5.82 
(ddt, 16.9, 10.0, 6.8) 
3.47 
(dt, 6.8, 0.9) 
 
5.28 
(br d, 8.1) 
6.95 
(br s) 
8c 
 
 
CDCl3 6.72 
(d, 2.7) 
7.13 
(d, 8.6) 
6.50 
(dd, 8.6, 2.7) 
5.01 
(dq, 16.8, 1.4) 
 
4.99 
(dq, 10.0, 0.9) 
 
5.81 
(ddt, 16.8, 10.0, 7.1) 
 
3.36 
(dt, 7.1, 1.0) 
 
3.34 
(br s) 
5.98 
(br s) 
 
 
 
DMSO-d6 6.54 
(d, 2.6) 
6.87 
(d, 8.5) 
6.39 
(dd, 8.5, 2.6) 
5.20 
(dq, 16.9, 1.4) 
5.06 
(dq, 10.0, 1.0) 
5.82 
(ddt, 16.9, 10.1, 6.8) 
3.47 
(dt, 6.8, 1.1) 
 
5.34 
(br d, 7.9) 
6.95 
(br s) 
 
Table 3 (continued). 
 
Comp 
 
Solvent 
 
H-8 
 
H-9 
 
H-10 
 
8-CH3 
 
10-CH3A 
 
4-CH3B 
Phenyl ring 
ortho                   meta                     para 
 
5 CDCl3 3.57 
(sept, 6.2) 
1.20 
(d, 6.3) 
– 1.20 
(d, 6.3) 
– – 6.88 – 6.93 
(m) 
7.16 – 7.23 
(m) 
6.78 – 6.85 
(m) 
 DMSO-d6 3.49 
(sept, 6.6) 
1.13 
(d, 6.3) 
– 1.13 
(d, 6.3) 
– – 6.56 – 6.60 
(m) 
7.00 – 7.07 
(m) 
6.53 – 6.57 
(m) 
6 CDCl3 3.46 
(sext, 6.7) 
1.25 (dt, 13.3, 6.9) 
1.46 (dt, 13.3, 6.9) 
1.75 
(sept, 6.8) 
1.15 
(d, 6.2) 
0.92 
(d, 6.6) 
0.94 
(d, 6.6) 
6.88 – 6.94 
(m) 
7.16 – 7.23 
(m) 
6.78 – 6.84 
(m) 
 DMSO-d6 3.42 
(sept, 6.8) 
1.21 (dt, 13.3, 6.9) 
1.45 (dt, 13.3, 6.9) 
1.73 
(sept, 6.7) 
1.07 
(d, 6.2) 
0.87 
(d, 6.6) 
0.92 
(d, 6.6) 
6.53 – 6.59 
(m) 
7.01 – 7.07 
(m) 
6.63 – 6.59 
(m) 
7 CDCl3 3.76 
(sext, 6.7) 
1.46 1.30 1.17 
(d, 6.3) 
– 1.36 6.88 – 6.94 
(m) 
7.17 – 7.24 
(m) 
6.79 – 6.85 
(m) 
 DMSO-d6 3.29 – 3.39 – – 1.09 
(d, 6.3) 
– – 6.52 – 6.59 
(m) 
7.00 – 7.07 
(m) 
6.52 – 6.59 
(m) 
8 CDCl3 3.19 
(tt, 9.8, 3.6) 
– – – – – 6.88 – 6.94 
(m) 
7.16 – 7.23 
(m) 
6.78 – 6.84 
(m) 
 DMSO-d6 3.09 – 3.20 
(unres m) 
– – – – – 6.51 – 6.56 
(m) 
7.00 – 7.07 
(m) 
6.52 – 6.59 
(m) 
 
a) 7 in CDCl3: δ 1.46 (H-2); δ 1.30  (H-3);  δ 1.36 (H-4); δ 1.28 (H-5); 1.31 (H-6); DMSO-d6: 0.86 (t, 7-CH3); 1.45  - 1.58 (m, H-2), 1.18 - 1.42 (unres m, H-3 + H-4 + 
H-5 + H-6);  b)  8 in DMSO-d6: 1.89 - 1.97 (m,  H-6eq + H-2eq); 1.68  – 1.76 (m,  H-5eq + H-4eq); 1.55 - 1.63 (m,  H-3eq); 1.22 - 1.39 (m,  H-3ax + H-5ax); 1.07 - 
1.24 (m, H-4ax + H-6ax + H-2ax); CDCl3: 2.01 - 2.09 (m,  H-6eq + H-2eq); 1.72 - 1.80 (m,  H-5eq + H-4eq); 1.61 - 1.69 (m,  H-3eq); 1.29 - 1.44 (m,  H-3ax + H-5ax); 
1.07 - 1.28 (m,  H-4ax + H-6ax + H-2ax). 
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Table  4.  Carbon-13 chemical shift assignments of   3-(allylsulfanyl)-N1-(alkyl)-N4-phenyl-1,4-benzenediamines 5−8 
 
 
 
 
 
Table 4  (continued).   
 
 
  
 
    a -  δ  21.07 (8-CH3),  δ  22.97 (10-CH3);  b -  20.43 (8-CH3) 
 
 
 
 
 
 
 
 
 
 
Comp Solvent C-1 C-2 C-3 C-4 C-5 C-6 Cipso Cortho Cmeta Cpara 
5 DMSO-d6 
CDCl3 
145.80 
142.95 
111.58 
118.43 
133.80 
133.64 
128.10 
133.64 
127.06 
121.71 
110.50 
114.32 
147.71 
145.18 
113.26 
115.90 
128.67 
129.19 
116.62 
119.51 
6 DMSO-d6 
CDCl3 
146.06 
143.24 
111.22 
118.08 
133.92 
127.03 
127.88 
133.37 
127.22 
121.93 
110.28 
114.06 
147.78 
145.28 
113.21 
115.82 
128.69 
129.19 
116.58 
118.08 
7 DMSO-d6 
CDCl3 
146.07 
143.25 
111.29 
118.14 
133.87 
127.03 
127.89 
133.38 
127.16 
121.92 
110.37 
114.10 
147.78 
145.28 
113.22 
115.82 
128.67 
129.19 
116.58 
119.45 
8 DMSO-d6 
CDCl3 
145.75 
142.91 
111.36 
118.25 
134.04 
127.01 
127.92 
133.48 
127.14 
121.88 
110.36 
114.20 
147.81 
145.26 
113.24 
115.84 
128.73 
129.20 
116.63 
119.47 
Comp Solvent SCH2 =CH =CH2 C-8 C-9 C-10 C-11 C-12 C-13 C-14 
5 CDCl3 
 
37.73 
 
133.66 
 
117.51 
 
44.83 
 
23.01 ─ ─ ─ ─ ─ 
 DMSO-d6 34.26 133.94 117.50 43.24 22.52 ─ ─ ─ ─ ─ 
6a CDCl3 37.70 133.68 117.52 47.15 46.89 25.06 22.56 ─ 
 
─ 
 
─ 
 DMSO-d6 
 
34.22 133.93 117.51 45.57 45.94 24.50 22.57 ─ ─ ─ 
7b CDCl3 
 
37.71 
 
133.68 
 
117.51 
 
49.13 
 
37.19 
 
29.35 
 
26.08 
 
31.81 
 
22.60 
 
13.94 
 DMSO-d6 36.33 133.95 117.47 47.53 34.24 28.84 25.65 31.34 22.07 ─ 
8 CDCl3 
 
37.75 
 
133.74 
 
117.53 
 
52.53 
 
33.54 
 
25.91 
 
25.01 
 
25.91 
 
33.54 
 
─ 
 DMSO-d6 34.22 134.13 117.54 50.77 32.71 32.71 25.63 24.57 32.71 ─ 
NHCH3 CH
CH3
NH
CH2
CH
CH3
NH
CH
CH3
CH3
CH2
CH
CH3
NH
CH2
CH2
CH2
CH2
CH3
8
11
10 9
810A
B
9
8
9
8
A
B
10
1113
14
12 13
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Table  5.  Proton chemical shift assignments of the N1-(alkyl)-2-methyl-N4- phenyl-2,3-dihydrobenzothiophene-4,7-diamines 9-12 
*- two set of overlapping sextets, **- two set overlapping doublet of doublets of doublets. 
Table 5  (continued). 
Comp Solvents 9-CH3 4-NH 7-NH ortho/Ph meta/Ph para/Ph 
9 CDCl3 1.21 (d, 6.3) 2.81 (br s) 5.11 (br s) 6.71 – 6.78  (m) 7.11 – 7.19  (m) 6.71 – 6.78  (m) 
 DMSO-d6 1.15 (d, 6.2) 4.36 (br d, 6.6) 7.04 (br s) 6.51 – 6.58  (m) 7.12 – 7.19  (m) 6.69 – 6.78  (m) 
10a CDCl3 1.17 and 1.18 (d, 6.2) 2.98 (br s) 5.10 (br s) 6.69 – 6.78  (m) 7.12 – 7.19 (m) 6.69 – 6.78  (m) 
 DMSO-d6 1.10 and 1.11 (d, 6.2) 4.33 and 4.34 (br d, 8.7) 7.13 (br s) 6.56 – 6.70  (m) 6.98 – 7.06 (m) 6.48 – 6.55 (m) 
11b CDCl3 1.18 (d, 6.3) 3.01 (br s) 5.10 (br s) 6.78 – 6.88  (m) 7.11 – 7.19  (m) 6.78 – 6.88  (m) 
 DMSO-d6 1.11 (d, 6.2) 4.32 and 4.33 (br d, 8.4) 7.09  (br s) 6.50 – 6.58  (m) 7.00 – 7.06  (m) 6.50 – 6.58  (m) 
12c CDCl3       ─ 3.04  (br s) 5.10 (br s) 6.72 – 6.80  (m) 7.11 – 7.19  (m) 6.72 – 6.80  (m) 
 DMSO-d6       ─ 4.37 (br d, 8.0) 7.11 (br s) 6.52 – 6.58  (m) 6.98 – 7.07  (m) 6.52 – 6.58   (m) 
a) 10 in CDCl3: δ 0.90 (d, 3J = 6.6, 11-CH3A), δ 0.91 (d, 3J = 6.3, 11-CH3B) and δ 0.92 (d, 3J = 6.3, 11-CH3B), 10 in DMSO-d6: δ 0.86 (d, 3J = 6.5, 11-
CH3A) and δ 0.87 (d, 3J = 6.5, 11-CH3A), δ 0.92 (d, 3J = 6.6, 11-CH3B); b) 11 in CDCl3: 0.89 (t, 6.9, 13-CH3), 1.17 (d, 6.3, 9-CH3), 1.18 (d, 6.3, 9-CH3),  
1.27 - 1.40 (unresolv multiplet, 10-CHAHB + 11-CH2 + 12-CH2+ 13-CH2 + 14-CH2), in DMSO-d6: 1.23 - 1.42 (unresolv multiplet, 10-CHAHB + 11-CH2 
+ 12-CH2 + 13-CH2 + 14-CH2), 0.86 (t, 6.9, 13-CH3),   c) 12  in CDCl3:   1.08 –1.28 (m,  12ax + 10ax + 10'ax), 1.28-1.41 (m,  11ax + 11'ax),  1.62 – 
1.69 (m,  12eq), 1.73–1.80 (m,  11eq + 11'eq), in DMSO-d6:   1.08 –1.39 (m,  10ax + 10'ax + 12ax + 11ax + 11'ax),  1.57–1.64  (m,  12eq), 1.68–1.75  
(m, 11eq  +  11eq'),  1.91 - 1.98 (m,  11eq +11'eq). 
Comp Solvent H-2 2-CH3 H-3 H-5 H-6 H-9 H-10 
9 CDCl3 3.98 
(sext, 7.1) 
1.44 
(d, 6.7) 
2.75 (ddd, 14.9, 6.6, 0.7) 
3.22 (ddd, 14.9, 7.9, 0.7) 
6.36 
(d, 8.5) 
6.98 
(d, 8.5) 
3.61 
(sept, 6.3) 
1.22 
(d, 6.2, CH3) 
 DMSO-d6 3.89 
(sext, 3.89) 
1.33 
(d, 6.7) 
2.79 (dd, 15.6, 6.5) 
3.25 (dd, 15.6, 7.8) 
6.30 
(d, 8.4) 
6.80 
(d, 8.4) 
3.54 
(sept, 6.3) 
1.16 
(d, 6.4, CH3) 
10 CDCl3 4.00 
(sext, 6.7)* 
1.45 (d, 6.8) 
1.46 (d, 6.8) 
2.75 (ddd, 14.8, 6.8, 0.7) 
2.76 (ddd, 14.8, 6.8, 0.7) 
3.23 (ddd, 14.8, 7.8, 0.7)** 
6.36 
(d, 8.7) 
6.99 
(d, 8.7) 
3.52 
(sext, 6.4) 
1.28 (dt, 13.7, 6.9) 
1.27 (dt, 13.7, 6.9) 
1.48 (dt, 13.7, 6.9 
 DMSO-d6 3.91* 
(sext, 6.7) 
1.35 
(d, 6.7) 
2.75 (dd, 15.8, 6.6) 
2.82 (dd, 15.8, 6.6) 
3.23 (dd, 15.7, 7.8) 
3.29 (dd, 15.7, 7.8) 
6.31 
(d, 8.4) 
6.82 
(d, 8.4) 
3.47* 
(sext, 6.8) 
1.25 (dt, 13.3, 6.7) 
1.23 (dt, 13.3, 6.7) 
1.53 (dt, 13.3, 6.7) 
11 CDCl3 3.99 
(sext, 6.8) 
1.45 
(d, 6.8) 
2.75 (dd, 14.8, 6.6) 
3.22 (dd, 14.8, 7.8) 
6.34 
(d, 8.6) 
6.98 
(d, 8.6) 
3.44 
(sext, 6.3) 
1.52-1.64 
(m, 1H) 
 DMSO-d6 3.91 
(sext, 6.7) 
 
1.35 
(d, 6.7) 
2.76 (dd, 15.8, 6.6) 
2.82 (dd, 15.8, 6.6) 
3.23 (dd, 15.8, 7.9) 
3.27 (dd, 15.7, 7.9) 
6.28 
(d, 8.7) 
6.80 
(d, 8.7) 
3.38 
(br m) 
1.52-1.62 
(m, 1H) 
12 CDCl3 
 
3.99 
(sext, 6.7) 
1.44 
(d, 6.8) 
2.76 (ddd, 14.9, 6.6, 0.7) 
3.23 (ddd, 14.9, 7.9, 0.7) 
6.37 
(dd, 8.4, 0.7) 
6.98 
(dt, 8.4, 
0.7) 
3.25 
(tt, 9.9, 3.8) 
2.03-2.94 
(m, 10eq+10’eq) 
 DMSO-d6 
 
3.91 
(sext, 6.6) 
1.44 
(d, 6.8) 
2.79 (dd, 15.7, 6.7) 
3.25 (dd, 15,7, 7.9) 
6.32 
(d, 8.7) 
6.79 
(d, 8.7) 
3.11-3.23 
(unresm) 
1,90-1.97 
(m, 10eq+10’eq) 
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Table  6.  Carbon-13 chemical shift assignments of the  2,3-dihydrobenzothiophene moiety and N4-phenyl ring * in 9-12 
Comp Solvent C-2 C-3 C-3a C-4 C-5 C-6 C-7 C-7a Cipso Cortho Cmeta Cpara 
9 CDCl3 44.34 41.50 123.98 140.67 108.55 123.79 126.48 137.75 145.77 114.71 129.07 118.68 
 DMSO-d6 43.37 41.49 125.07 141.26 107.78 125.15 123.67 138.65 147.00 113.36 128.61 116.56 
10 CDCl3 44.40 
44.37 
41.61 
41.60 
123.81 
─ 
140.88 
140.86 
108.23 
108.21 
123.90 
─ 
126.25 
─ 
137.83 
137.80 
145.80 
142.90 
114.69 
─ 
129.07 
─ 
118.59 
─ 
 DMSO-d6 43.45 
43.37 
41.59 
─ 
123.54 
123.48 
141.51 
─ 
107.41 
107.39 
124.83 
─ 
125.34 
─ 
138.84 
138.79 
147.10 
─ 
113.36 
─ 
128.67 
─ 
116.55 
─ 
11 CDCl3 44.40 
44.37 
41.58 
─ 
123.81 
123.78 
140.86 
─ 
108.37 
108.33 
123.88 
─ 
126.25 
126.24 
137.78 
─ 
145.78 
─ 
114.67 
─ 
129.05 
─ 
118.57 
─ 
 DMSO-d6 43.37 
43.33 
41.52 
─ 
123.51 
123.47 
141.48 
─ 
107.62 
107.55 
125.21 
─ 
124.88 
124.86 
138.71 
─ 
147.05 
─ 
113.34 
─ 
128.59 
─ 
116.52 
─ 
12 CDCl3 44.42 41.58 123.85 140.56 108.51 123.86 126.32 137.81 145.79 114.64 129.06 118.57 
 DMSO-d6 43.37 41.48 123.58 141.11 107.76 124.98 125.22 138.75 146.06 113.33 128.65 116.55 
* - Numbering of carbon atoms is given in Scheme 2. 
Table 6 (continued).  
 
Comp Solvent 2-CH3 C-9 9-CH3A 9-CH3B C-10 C-11 11-CH3A 11-CH3B 
       9 CDCl3 22.37 44.50 23.16 23.21 ─ ─ ─ ─ 
 DMSO-d6 22.41 43.51 22.54 22.58 ─ ─ ─ ─ 
       10 CDCl3 22.43 
─ 
46.93 
46.90 
─ 
─ 
21.41 
21.37 
47.08 
47.06 
25.14 
   ─ 
22.54 
22.51 
23.01 
22.99 
 DMSO-d6 22.43 
─ 
46.91 
46.90 
─ 
─ 
21.41 
21.38 
47.08 
47.06 
25.14 
25.13 
22.54 
22.51 
23.01 
23.00 
       11a CDCl3 22.48 
22.43 
48.87 
─ 
─ 
─ 
21.09 
21.06 
37.35 
37.32 
29.31 
─ 
26.08* 
26.07* 
31.79** 
─ 
 DMSO-d6 22.41 
22.31 
47.91 
47.89 
─ 
─ 
20.51 
─ 
36.27 
 ─ 
28.81 
28.80 
25.76* 
25.74 * 
31.31** 
─ 
       12 CDCl3 22.47 52.07 ─ ─ 33.74 
33.78 
25.01 
24.99 
25.89 
(C-12) 
─ 
 DMSO-d6 22.41 51.23 ─ ─ 32.77 
32.78 
24.81 
24.88 
25.61 
(C-12) 
─ 
a) 11 in CDCl3: δ 22.58 (C-14), δ 14.06 (14-CH3); DMSO-d6: δ 22.05 and δ 22.06 (C-14), δ 13.92 (14-CH3). (C-12); *- (C-12), ** - (C-13). 
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Table 7.  Proton   chemical shift assignments of N5-(isopropyl)-N8-phenyl-5,8-thiochromanediamine and N5-(cyclohexyl)- 
N8-phenyl –5,8-thiochromanediamine 13, 14 
 
 
 
 
Comp Solvent H-2 H-3 H-4 H-6 H-7 H-9 5-NH 8-NH 
13a CDCl3 2.50 
(t, 6.3) 
2.15-2.23 
(m) 
2.87-2.91 
(m) 
6.43 
(d, 8.7) 
7.03 
(d, 8.7) 
3.65 
(sept, 6.2) 
3.42 
(br s) 
5.24 
(br s) 
 DMSO-d6 2.48 
(t, 6.3) 
1.98-2.04 
(m) 
2.78-2.83 
(m) 
6.35 
(d, 8.5) 
6.81 
(d, 8.5) 
3.57 
(unresol m) 
4.25 
(br s) 
6.88 
(br s) 
14 CDCl3 2.49 
(t, 6.4) 
2.16-2.21 
(m) 
2.85-2.89 
(m) 
6.42 
(d, 8.6) 
7.01 
(d, 8.6) 
3.22-3.32 
(unresol m) 
3.23 
(br s) 
5.09 
(br s) 
 DMSO-d6 2.47 
(t, 6.4) 
1.99-2.04 
(m) 
2.78-2.81 
(m) 
6.36 
(d, 8.6) 
6.80 
d, 8.6) 
3.18-3.28 
(unresol m) 
4.20 
(br s) 
6.87 
(br s) 
a – in CDCl3: δ 1.26 (d, 3J = 6.2, 9-CH3), in DMSO-d6: δ 1.18 (d, 3J = 6.3, 9-CH3). 
Table 7  (continued). 
Comp Solvent 10eq + 10'eq 11eq + 11'eq 12eq ortho/Ph meta/Ph para/Ph 
13 CDCl3 – – – 6.70 – 6.77 
(m) 
7.13 – 7.19 
(m) 
6.70 – 6.77 
(m) 
 DMSO-d6 – – – 6.50 – 6.56 
(m) 
6.98 – 7.05 
(m) 
6.50 – 6.56 
(m) 
14a CDCl3 2.04 – 2.10 
(m) 
1.73 – 1.80 
(m) 
1.64 – 1.68 
(m) 
6.68 – 6.71 
(m) 
7.11 – 7.19 
(m) 
6.70 – 6.76 
(m) 
 DMSO-d6 1.92 – 1.98 
(m) 
1.68 – 1.73 
(m) 
1.58 – 1.63 
(m) 
6.49 – 6.56 
(m) 
6.98 – 7.04 
(m) 
6.49 – 6.56 
(m) 
a – in CDCl3: δ 1.12 – 1.30 (m, 10ax + 10'ax), 1.31 – 1.42 (m, 11ax + 11'ax + 12ax), in DMSO-d6: 1.14 – 1.36 (m, 10ax + 10'ax + 11ax + 
11'ax + 12ax). 
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Table 8.  Carbon-13 chemical shift   assignments of N5-(isopropyl)-N8-phenyl-5,8-thiochromanediamine and N5-(cyclohexyl)- 
N8-phenyl –5,8-thiochromanediamine 13, 14 
Comp Solvent C-2 C-3 C-4 C-4a C-5 C-6 C-7 C-8 C-8a 
13 CDCl3 22.04 21.61 24.55 116.31 142.79 106.29 123.88 126.91 131.02 
 DMSO-d6 23.37 22.71 25.40 118.45 143.39 106.35 124.99 126.72 132.12 
14 CDCl3 23.64 23.09 26.19 118.61 142.25 106.83 123.87 127.60 131.03 
 DMSO-d6 23.35 22.74 25.61 118.30 143.16 106.26 124.98 126.76 132.18 
                   N8- phenyl ring             N5-alkyl substituents 
Comp Solvent Cipso Cortho Cmeta Cpara C-9 9-CH3A 9-CH3B C-11 C-12 
13 CDCl3 146.76 114.29 129.14 118.40 44.36 21.58 21.58 ─ ─ 
 DMSO-d6 148.09 113.06 128.61 116.31 45.51 22.54 22.54 ─ ─ 
14 CDCl3 146.71 114.17 129.07 118.29 51.78 33.62* ─ 24.98 25.93 
 DMSO-d6 148.10 113.04 128.60 116.28 51.16 32.70* ─ 24.78 25.39 
* - (C-10) 
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                                  Figure 1.   Perspective view of the X-ray structure of 5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Expansion of the 1H NMR spectrum of 8 (in DMSO-d6) in the range of 
                                CH2=CH-CH2R group. 
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                Figure 3. 1H NMR spectrum (a) of 9 in DMSO-d6;  (b) - (d)  NOE difference  
                                spectra; arrows indicate irradiated peaks 
 
 
 
 
 
Figure 4.   Perspective view of the X-ray structure of 9, showing the disorder within the five-membered ring.  
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Figure 5.   Methyl region of 1H NMR spectrum of 10 in CDCl3. (double set of  2-CH3, 9-CH3 and  11-CH3 and also H-10 
resonances indicate the presence of two chiral centers, at C-2 and C-9 carbon atoms, in molecule 10. The 1H NMR spectrum 
was processed using Lorentz/Gaussian window functions (lb = -0.5 gf = 1.6) prior to Fourier transformations and zero filled by 
128 K, to get resolution-enhanced spectrum. 
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Figure 7. Portion of the 1H NMR spectrum of 10 in CDCl3, (a) without 
irradiation; (b) with irradiation of H-2 resonance at δ 4.0, for processing 
FID’s was used line broadening function (lb = 1); (c) with irradiation of 
doublet at δ 6.99 (H-6) of the  benzothiophene moiety  causes  two set 
doublet of doublets from two diastereomeric formic for H-3α and H-3β; 
(d) doublet of triplet at δ 6.99 (H-6); (e) irradiation of  H-3α  signal at  
δ .2.75.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
